The LC–MS-based metabolomics of hydroxytyrosol administration in rats reveals amelioration of the metabolic syndrome.

MLA

Lemonakis, Nikolaos, et al. “The LC–MS-Based Metabolomics of Hydroxytyrosol Administration in Rats Reveals Amelioration of the Metabolic Syndrome.” Journal of Chromatography B: Analytical Technologies in the Biomedical & Life Sciences, vol. 1041, Jan. 2017, pp. 45–59. EBSCOhost, https://doi.org/10.1016/j.jchromb.2016.12.020.

APA

Lemonakis, N., Poudyal, H., Halabalaki, M., Brown, L., Tsarbopoulos, A., Skaltsounis, A.-L., & Gikas, E. (2017). The LC–MS-based metabolomics of hydroxytyrosol administration in rats reveals amelioration of the metabolic syndrome. Journal of Chromatography B: Analytical Technologies in the Biomedical & Life Sciences, 1041, 45–59. https://doi.org/10.1016/j.jchromb.2016.12.020

Chicago

Lemonakis, Nikolaos, Hemant Poudyal, Maria Halabalaki, Lindsay Brown, Anthony Tsarbopoulos, Alexios-Leandros Skaltsounis, and Evagelos Gikas. 2017. “The LC–MS-Based Metabolomics of Hydroxytyrosol Administration in Rats Reveals Amelioration of the Metabolic Syndrome.” Journal of Chromatography B: Analytical Technologies in the Biomedical & Life Sciences 1041 (January): 45–59. doi:10.1016/j.jchromb.2016.12.020.